441 related articles for article (PubMed ID: 23661492)
1. Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial.
Jensen TW; Hansen MS; Hørslev-Petersen K; Hyldstrup L; Abrahamsen B; Langdahl B; Zerahn B; Pødenphant J; Stengaard-Petersen K; Junker P; Østergaard M; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; Lindegaard H; Jurik AG; Vestergaard A; Hetland ML;
Ann Rheum Dis; 2014 Jun; 73(6):1123-9. PubMed ID: 23661492
[TBL] [Abstract][Full Text] [Related]
2. Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study.
Hetland ML; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Svendsen A; Pedersen JK; Skjødt H; Lauridsen UB; Ellingsen T; Hansen GV; Lindegaard H; Vestergaard A; Jurik AG; Østergaard M; Hørslev-Petersen K;
Ann Rheum Dis; 2008 Jun; 67(6):815-22. PubMed ID: 17878209
[TBL] [Abstract][Full Text] [Related]
3. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
Lems WF; Lodder MC; Lips P; Bijlsma JW; Geusens P; Schrameijer N; van de Ven CM; Dijkmans BA
Osteoporos Int; 2006; 17(5):716-23. PubMed ID: 16463007
[TBL] [Abstract][Full Text] [Related]
4. Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial.
Ørnbjerg LM; Østergaard M; Jensen T; Hørslev-Petersen K; Stengaard-Pedersen K; Junker P; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Lottenburger T; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Hetland ML; ; Slot O; Nielsen LK; Skjødt H; Majgaard O; Lorenzen T; Horn HC; Kowalski M; Johansen IL; Pedersen PM; Manilo N; Bliddal H
Clin Rheumatol; 2017 Apr; 36(4):781-789. PubMed ID: 27921185
[TBL] [Abstract][Full Text] [Related]
5. [Clinical trial for differentiation between corticoid-induced osteoporosis and periarticular demineralization via digital radiogrammetry in patients suffering from rheumatoid arthritis].
Böttcher J; Pfeil A; Lehmann G; Heinrich B; Malich A; Hansch A; Petrovitch A; Mentzel HJ; Hein G; Kaiser WA
Z Rheumatol; 2004 Dec; 63(6):473-82. PubMed ID: 15605213
[TBL] [Abstract][Full Text] [Related]
6. Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial.
Hetland ML; Stengaard-Pedersen K; Junker P; Østergaard M; Ejbjerg BJ; Jacobsen S; Lottenburger T; Hansen I; Tarp U; Andersen LS; Svendsen A; Pedersen JK; Lauridsen UB; Ellingsen T; Lindegaard H; Pødenphant J; Vestergaard A; Jurik AG; Hørslev-Petersen K;
Ann Rheum Dis; 2010 Oct; 69(10):1789-95. PubMed ID: 20444751
[TBL] [Abstract][Full Text] [Related]
7. Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis.
Buckley LM; Leib ES; Cartularo KS; Vacek PM; Cooper SM
J Rheumatol; 1997 Aug; 24(8):1489-94. PubMed ID: 9263140
[TBL] [Abstract][Full Text] [Related]
8. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA).
Hetland ML; Ejbjerg B; Hørslev-Petersen K; Jacobsen S; Vestergaard A; Jurik AG; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Skjødt H; Pedersen JK; Majgaard O; Svendsen AJ; Ellingsen T; Lindegaard H; Christensen AF; Vallø J; Torfing T; Narvestad E; Thomsen HS; Ostergaard M;
Ann Rheum Dis; 2009 Mar; 68(3):384-90. PubMed ID: 18388160
[TBL] [Abstract][Full Text] [Related]
9. Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?
van der Goes MC; Jacobs JW; Jurgens MS; Bakker MF; van der Veen MJ; van der Werf JH; Welsing PM; Bijlsma JW
Osteoporos Int; 2013 Apr; 24(4):1429-36. PubMed ID: 23011680
[TBL] [Abstract][Full Text] [Related]
10. Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis.
Güler-Yüksel M; Allaart CF; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; van Groenendael JH; Mallée C; de Bois MH; Breedveld FC; Dijkmans BA; Lems WF
Ann Rheum Dis; 2009 Mar; 68(3):330-6. PubMed ID: 18375540
[TBL] [Abstract][Full Text] [Related]
11. Striking difference of periarticular bone density change in early psoriatic arthritis and rheumatoid arthritis following anti-rheumatic treatment as measured by digital X-ray radiogrammetry.
Szentpetery A; Heffernan E; Haroon M; Kilbane M; Gallagher P; McKenna MJ; FitzGerald O
Rheumatology (Oxford); 2016 May; 55(5):891-6. PubMed ID: 26850991
[TBL] [Abstract][Full Text] [Related]
12. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.
Tascioglu F; Colak O; Armagan O; Alatas O; Oner C
Rheumatol Int; 2005 Nov; 26(1):21-9. PubMed ID: 15688191
[TBL] [Abstract][Full Text] [Related]
13. The CIMESTRA study: intra-articular glucocorticosteroids and synthetic DMARDs in a treat-to-target strategy in early rheumatoid arhtritis.
Hetland ML; Hørslev-Petersen K
Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S44-9. PubMed ID: 23079125
[TBL] [Abstract][Full Text] [Related]
14. Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study.
Hetland ML; Stengaard-Pedersen K; Junker P; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen A; Tarp U; Pødenphant J; Hansen G; Lindegaard H; de Carvalho A; Østergaard M; Hørslev-Petersen K;
Arthritis Rheum; 2006 May; 54(5):1401-9. PubMed ID: 16645967
[TBL] [Abstract][Full Text] [Related]
15. Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis.
Book C; Karlsson M; Akesson K; Jacobsson L
Scand J Rheumatol; 2008; 37(4):248-54. PubMed ID: 18612924
[TBL] [Abstract][Full Text] [Related]
16. Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA).
Møller-Bisgaard S; Ejbjerg BJ; Eshed I; Hørslev-Petersen K; Hetland ML; Jurik AG; Thomsen H; Torfing T; Stengaard-Pedersen K; Junker P; Krogh NS; Lottenburger T; Ellingsen T; Andersen LS; Skjødt H; Svendsen AJ; Tarp U; Hansen IT; Pødenphant J; Pedersen JK; Lindegaard H; Hanson LG; Vestergaard A; Glinatsi D; Østergaard M
Scand J Rheumatol; 2017 Sep; 46(5):335-345. PubMed ID: 27775461
[TBL] [Abstract][Full Text] [Related]
17. Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis.
Planas J; Trilla E; Raventós C; Cecchini L; Orsola A; Salvador C; Placer J; Encabo G; Morote J
BJU Int; 2009 Dec; 104(11):1637-40. PubMed ID: 19549260
[TBL] [Abstract][Full Text] [Related]
18. Hand bone loss measured by digital X-ray radiogrammetry is a predictor of joint damage in early rheumatoid arthritis.
Forslind K; Boonen A; Albertsson K; Hafström I; Svensson B;
Scand J Rheumatol; 2009; 38(6):431-8. PubMed ID: 19922017
[TBL] [Abstract][Full Text] [Related]
19. Changes in macrophage inhibitory factor correlate with changes in bone mineral density in glucocorticoid-treated patients with rheumatoid arthritis.
Hoes JN; Van der Goes MC; Jacobs JW; Lafeber FP; Bijlsma JW; Van Roon JA
Rheumatology (Oxford); 2011 Oct; 50(10):1921-4. PubMed ID: 21852299
[TBL] [Abstract][Full Text] [Related]
20. Decrease in bone mineral density during three months after diagnosis of early rheumatoid arthritis measured by digital X-ray radiogrammetry predicts radiographic joint damage after one year.
Ziegelasch M; Forslind K; Skogh T; Riklund K; Kastbom A; Berglin E
Arthritis Res Ther; 2017 Sep; 19(1):195. PubMed ID: 28865482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]